Page last updated: 2024-11-05

3-isopropylphenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Isopropylphenol, also known as 3-(1-methylethyl)phenol, is a colorless to pale yellow liquid with a phenolic odor. It is a monohydric phenol with an isopropyl group attached to the aromatic ring at the meta position. 3-Isopropylphenol is a natural compound found in plants and is also a synthetically produced chemical. It is used as an intermediate in the synthesis of various pharmaceuticals, pesticides, and other chemicals. 3-Isopropylphenol has been reported to exhibit antioxidant and antimicrobial properties. It is also a known irritant and can cause skin and eye irritation upon contact. Research on 3-isopropylphenol is conducted to investigate its potential applications in various fields, including medicine, agriculture, and chemical synthesis. The compound is studied to understand its biological activities, environmental impact, and potential toxicity.'

3-isopropylphenol: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12059
CHEMBL ID449684
SCHEMBL ID51528
MeSH IDM0092073

Synonyms (51)

Synonym
4-06-00-03214 (beilstein handbook reference)
unii-erd00478gh
erd00478gh ,
ec 291-826-2
90480-88-9
einecs 291-826-2
nsc-2209
isopropylphenol, meta
m-isopropylphenol
3-isopropylphenol
618-45-1
nsc2209
m-cumenol
phenol, 3-(1-methylethyl)-
phenol, m-isopropyl-
ai3-18885
3-isopropylhydroxybenzene
einecs 210-551-0
brn 2040880
nsc 2209
m-isopropyl-phenol
3-isopropylphenol, 97%
3-propan-2-ylphenol
CHEMBL449684
AKOS000121413
cas-618-45-1
dtxsid0044571 ,
NCGC00255721-01
tox21_301558
dtxcid8024571
FT-0615932
3-(1-methylethyl)phenol
SCHEMBL51528
isopropylphenol, m-
propofol impurity f [ep impurity]
m-isopropyl phenol
meta-isopropylphenol
3-isopropyl-phenol
3-isopropyl phenol
3-(propan-2-yl)phenol
1219805-35-2
3-iso-propylphenol-d12
mfcd00002301
3-(1-methylethyl)phenol; propofol imp. f (ep); propofol impurity f
carvacrol derivative, 10
bdbm248167
AS-10581
Q27277323
D87686
EN300-21143
Z104492878
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency74.81840.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.18140.006038.004119,952.5996AID1159523
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Secreted chorismate mutaseMycobacterium tuberculosis H37RvIC50 (µMol)21.40000.99001.27251.9600AID1803444
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID1173482Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 4 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173475Anticonvulsant activity against CF1 albino mouse seizure model assessed as protection at 100 mg/kg, ip after 0.5 hrs by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173478Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 0.25 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173479Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 0.5 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173469Anticonvulsant activity against CF1 albino mouse seizure model assessed as time to peak effect at 100 mg/kg, ip by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1173488Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 1 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173490Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 4 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173476Anticonvulsant activity against CF1 albino mouse seizure model assessed as protection at 100 mg/kg, ip after 1 hrs by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173486Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 0.25 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173473Protective index, ratio of TD50 for CF1 albino mouse neurotoxicity to ED50 for protection against 6 Hz electroshock-induced seizure in CF1 albino mouse2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173468Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.5 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173471Neurotoxicity in CF1 albino mouse seizure model assessed as time to peak toxic effect at 100 mg/kg, ip after 4 hr by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173470Anticonvulsant activity against ip dosed CF1 albino mouse seizure model after 4 hrs by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173472Neurotoxicity in ip dosed CF1 albino mouse seizure model after 4 hr by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173467Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.25 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173489Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 2 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1803444CM Assay from Article 10.3109/14756366.2013.823958: \\Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.\\2014Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 29, Issue:4
Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.75 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index31.50 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]